KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Divestments (2019 - 2022)

Historic Divestments for Boston Scientific (BSX) over the last 9 years, with Q1 2022 value amounting to $5.0 million.

  • Boston Scientific's Divestments fell 9937.58% to $5.0 million in Q1 2022 from the same period last year, while for Dec 2022 it was $5.0 million, marking a year-over-year decrease of 9939.47%. This contributed to the annual value of $5.0 million for FY2022, which is 9939.47% down from last year.
  • As of Q1 2022, Boston Scientific's Divestments stood at $5.0 million, which was down 9937.58% from $25.0 million recorded in Q4 2021.
  • In the past 5 years, Boston Scientific's Divestments registered a high of $801.0 million during Q1 2021, and its lowest value of $5.0 million during Q1 2022.
  • Over the past 4 years, Boston Scientific's median Divestments value was $25.0 million (recorded in 2021), while the average stood at $187.2 million.
  • Examining YoY changes over the last 5 years, Boston Scientific's Divestments showed a top increase of 9937.58% in 2022 and a maximum decrease of 9937.58% in 2022.
  • Quarter analysis of 4 years shows Boston Scientific's Divestments stood at $90.0 million in 2019, then plummeted by 83.33% to $15.0 million in 2020, then soared by 66.67% to $25.0 million in 2021, then crashed by 80.0% to $5.0 million in 2022.
  • Its last three reported values are $5.0 million in Q1 2022, $25.0 million for Q4 2021, and $801.0 million during Q1 2021.